☰

Priya B. Batheja, Ph.D. - Publications

Affiliations: 
2010 Graduate School - New Brunswick Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

3/6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak-Kohn B. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies. Journal of Controlled Release : Official Journal of the Controlled Release Society. 149: 159-67. PMID 20950659 DOI: 10.1016/J.Jconrel.2010.10.005  0.713
2009 Batheja P, Song Y, Wertz P, Michniak-Kohn B. Effects of growth conditions on the barrier properties of a human skin equivalent. Pharmaceutical Research. 26: 1689-700. PMID 19415472 DOI: 10.1007/S11095-009-9879-1  0.729
2008 Sheihet L, Chandra P, Batheja P, Devore D, Kohn J, Michniak B. Tyrosine-derived nanospheres for enhanced topical skin penetration International Journal of Pharmaceutics. 350: 312-319. PMID 17897801 DOI: 10.1016/J.Ijpharm.2007.08.022  0.601
Low-probability matches (unlikely to be authored by this person)
2006 Batheja P, Priya B, Thakur R, Rashmi T, Michniak B, Bozena M. Transdermal iontophoresis. Expert Opinion On Drug Delivery. 3: 127-38. PMID 16370945 DOI: 10.1517/17425247.3.1.127  0.273
2008 Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. Percutaneous permeation modifiers: enhancement versus retardation. Expert Opinion On Drug Delivery. 5: 517-29. PMID 18491979 DOI: 10.1517/17425247.5.5.517  0.237
2023 Amore BM, Patel N, Batheja P, Templeton IE, Jones HM, Louie MJ, Emery MG. Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation. Pharmaceutics. 15. PMID 37242718 DOI: 10.3390/pharmaceutics15051476  0.113
Hide low-probability matches.